PlumX Metrics
SSRN
Embed PlumX Metrics

The Privacy Risks of Direct-to-Consumer Genetic Testing: A Case Study of 23andMe and Ancestry

Washington University Law Review, Vol. 96, 2019
2019
  • 2
    Citations
  • 2,764
    Usage
  • 4
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    2
    • Citation Indexes
      2
  • Usage
    2,764
    • Abstract Views
      2,152
    • Downloads
      612
  • Captures
    4
    • Readers
      4
      • SSRN
        4
  • Ratings
    • Download Rank
      90,177

Paper Description

Direct-to-consumer genetic testing (DTC-GT) companies have proliferated and expanded in recent years. Using biospecimens directly submitted by consumers, these companies sequence and analyze the individual’s genetic information to provide a wide range of services including information on health and ancestry without the guidance of a healthcare provider. Given the sensitive nature of genetic information, however, there are growing privacy concerns regarding DTC-GT company data practices. We conduct a rigorous analysis, both descriptive and normative, of the privacy policies and associated privacy risks and harms of the DTC-GT services of two major companies, 23andMe and Ancestry, and evaluate to what extent consumers’ genetic privacy is protected by the policies and practices of these two companies. Despite the exceptional nature of genetic information, the laws and agency regulation surrounding genetic privacy and DTC-GT services are fragmented and insufficient. In this analysis, we propose three categories of privacy harms specific to DTC-GT— knowledge harms, autonomy and trust-based harms, and data misuse harms. Then, through the normative lens of exploitation, we argue that 23andMe and Ancestry’s data practices and privacy policies provide consumers with insufficient protection against these harms. Greater efforts from both the industry and legal system are necessary to protect DTC-GT consumers’ genetic privacy as we advance through the era of genomics and precision medicine.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know